Genflow Biosciences plc
GENF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | -£0 | -£0 | -£0 | £0 |
| % Margin | – | – | – | – |
| R&D Expenses | £1 | £1 | £1 | £0 |
| G&A Expenses | £2 | £2 | £0 | £1 |
| SG&A Expenses | £2 | £1 | £1 | £1 |
| Sales & Mktg Exp. | £0 | -£1 | £0 | £0 |
| Other Operating Expenses | -£1 | £0 | -£0 | £0 |
| Operating Expenses | £2 | £2 | £1 | £1 |
| Operating Income | -£1 | -£2 | -£1 | -£1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -£0 | £0 | -£0 | -£0 |
| Pre-Tax Income | -£2 | -£2 | -£1 | -£1 |
| Tax Expense | £0 | -£0 | £0 | £0 |
| Net Income | -£2 | -£2 | -£1 | -£1 |
| % Margin | – | – | – | – |
| EPS | -0.005 | -0.006 | -0.005 | -0.003 |
| % Growth | 16.1% | -21.7% | -35.3% | – |
| EPS Diluted | -0.005 | -0.006 | -0.005 | -0.003 |
| Weighted Avg Shares Out | 335 | 293 | 293 | 293 |
| Weighted Avg Shares Out Dil | 334 | 293 | 293 | 293 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£2 | -£2 | -£1 | -£1 |
| % Margin | – | – | – | – |